Risk of cancer and serious disease in Danish patients with urgent referral for serious non-specific symptoms and signs of cancer in Funen 2014–2021

被引：0
|
作者：
Rasmus Birkholm Grønnemose
Per Syrak Hansen
Søren Worsøe Laursen
Oke Gerke
Jakob Kjellberg
Jesper Lykkegaard
Clara Thye-Rønn
Poul Flemming Høilund-Carlsen
Peter Thye-Rønn
机构：
[1] Odense University Hospital,Diagnostic Centre, Svendborg Hospital
[2] The Danish Cancer Society,Department of Nuclear Medicine
[3] Odense University Hospital,Department of Clinical Research, Faculty of Health Sciences
[4] University of Southern Denmark,VIVE
[5] The Danish Centre for Social Science Research,Research Unit of General Practice
[6] University of Southern Denmark,undefined
来源：
British Journal of Cancer | 2024年 / 130卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1304 / 1315
页数：11
相关论文
共 50 条
  • [31] Undergoing Diagnostic Evaluation for Possible Cancer Affects the Health-Related Quality of Life in Patients Presenting with Non-Specific Symptoms
    Moseholm, Ellen
    Rydahl-Hansen, Susan
    Lindhardt, Bjarne Orskov
    PLOS ONE, 2016, 11 (02):
  • [32] HOW LONG DO PATIENTS IN THE UK GET TREATED FOR NON-SPECIFIC RESPIRATORY SYMPTOMS BY GENERAL PRACTITIONERS BEFORE THEY ARE DIAGNOSED WITH LUNG CANCER?
    Iyen-Omofoman, B.
    Tata, L.
    Hubbard, R.
    JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH, 2011, 65 : A191 - A191
  • [33] Non-specific symptoms as a prodrome of immune-related adverse events in patients with non-small cell lung cancer receiving nivolumab: a consecutive analysis of 200 patients
    Higashiyama, Ryoko Inaba
    Horinouchi, Hidehito
    Kuchiba, Aya
    Matsumoto, Yuji
    Murakami, Shuji
    Goto, Yasushi
    Kanda, Shintaro
    Fujiwara, Yutaka
    Yamamoto, Noboru
    Ohe, Yuichiro
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (07) : 3185 - 3191
  • [34] Non-specific symptoms as a prodrome of immune-related adverse events in patients with non-small cell lung cancer receiving nivolumab: a consecutive analysis of 200 patients
    Ryoko Inaba Higashiyama
    Hidehito Horinouchi
    Aya Kuchiba
    Yuji Matsumoto
    Shuji Murakami
    Yasushi Goto
    Shintaro Kanda
    Yutaka Fujiwara
    Noboru Yamamoto
    Yuichiro Ohe
    Journal of Cancer Research and Clinical Oncology, 2023, 149 : 3185 - 3191
  • [35] A UK population-based case-control study of blood tests before cancer diagnosis in patients with non-specific abdominal symptoms
    Rafiq, Meena
    White, Becky
    Barclay, Matthew
    Abel, Gary
    Renzi, Cristina
    Lyratzopoulos, Georgios
    BRITISH JOURNAL OF CANCER, 2025, 132 (05) : 450 - 461
  • [36] How Long Do Patients In The United Kingdom Get Treated For Non-Specific Respiratory Symptoms By General Practitioners Before They Are Diagnosed With Lung Cancer?
    Iyen-Omofoman, B.
    Tata, L.
    Hubbard, R.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2011, 183
  • [37] Health-related quality of life in patients with non-specific symptoms that undergo diagnostic investigations for cancer: The impact of socio-demographic and medical characteristics
    Larsen, E. Moseholm
    Rydahl-Hansen, S.
    Lindhardt, B. O.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S223 - S223
  • [38] Whole-Body 18F-FDG PET/CT Is Superior to CT as First-Line Diagnostic Imaging in Patients Referred with Serious Nonspecific Symptoms or Signs of Cancer: A Randomized Prospective Study of 200 Patients
    Lebech, Anne-Mette
    Gaardsting, Anne
    Loft, Annika
    Graff, Jesper
    Markova, Elena
    Bertelsen, Anne Kiil
    Madsen, Jan Lysgard
    Andersen, Kim Francis
    von Benzon, Eric
    Helms, Morten
    Mathiesen, Lars R.
    David, Kim P.
    Kronborg, Gitte
    Kjaer, Andreas
    JOURNAL OF NUCLEAR MEDICINE, 2017, 58 (07) : 1058 - 1064
  • [39] A new risk stratification model for intravesical recurrence, disease progression, and cancer-specific death in patients with non-muscle invasive bladder cancer: the J-NICE risk tables
    Makito Miyake
    Hideyasu Matsuyama
    Satoshi Teramukai
    Fumie Kinoshita
    Isao Yokota
    Hiroaki Matsumoto
    Keiji Shimada
    Mitsuru Kinjyo
    Tatsuro Shimokama
    Koji Okumura
    Masaya Yomenori
    Hideki Enokida
    Masayuki Nakagawa
    Yasushi Nakai
    Kiyohide Fujimoto
    International Journal of Clinical Oncology, 2020, 25 : 1364 - 1376
  • [40] A new risk stratification model for intravesical recurrence, disease progression, and cancer-specific death in patients with non-muscle invasive bladder cancer: the J-NICE risk tables
    Miyake, Makito
    Matsuyama, Hideyasu
    Teramukai, Satoshi
    Kinoshita, Fumie
    Yokota, Isao
    Matsumoto, Hiroaki
    Shimada, Keiji
    Kinjyo, Mitsuru
    Shimokama, Tatsuro
    Okumura, Koji
    Yomenori, Masaya
    Enokida, Hideki
    Nakagawa, Masayuki
    Nakai, Yasushi
    Fujimoto, Kiyohide
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2020, 25 (07) : 1364 - 1376
12345